TY - JOUR
T1 - Co-occurrence of fragile x syndrome with a second genetic condition: Three independent cases of double diagnosis
AU - Tabolacci, Elisabetta
AU - Pomponi, Maria Grazia
AU - Remondini, Laura
AU - Pietrobono, Roberta
AU - Orteschi, Daniela
AU - Nobile, Veronica
AU - Pucci, Cecilia
AU - Musto, Elisa
AU - Pane, Marika
AU - Mercuri, Eugenio Maria
AU - Neri, Giovanni
AU - Genuardi, Maurizio
AU - Chiurazzi, Pietro
AU - Zollino, Marcella
PY - 2021
Y1 - 2021
N2 - Fragile X syndrome (FXS) is the most common form of inherited intellectual disability and autism caused by the instability of a CGG trinucleotide repeat in exon 1 of the FMR1 gene. The co-occurrence of FXS with other genetic disorders has only been occasionally reported. Here, we describe three independent cases of FXS co-segregation with three different genetic conditions, consisting of Duchenne muscular dystrophy (DMD), PPP2R5D–related neurodevelopmental disorder, and 2p25.3 deletion. The co-occurrence of DMD and FXS has been reported only once in a young boy, while in an independent family two affected boys were described, the elder diagnosed with FXS and the younger with DMD. This represents the second case in which both conditions coexist in a 5-year-old boy, inherited from his heterozygous mother. The next double diagnosis had never been reported before: through exome sequencing, a girl with FXS who was of 7 years of age with macrocephaly and severe psychomotor delay was found to carry a de novo variant in the PPP2R5D gene. Finally, a maternally inherited 2p25.3 deletion associated with a decreased level of the MYT1L transcript, only in the patient, was observed in a 33-year-old FXS male with severe seizures compared to his mother and two sex-and age-matched controls. All of these patients represent very rare instances of genetic conditions with clinical features that can be modified by FXS and vice versa.
AB - Fragile X syndrome (FXS) is the most common form of inherited intellectual disability and autism caused by the instability of a CGG trinucleotide repeat in exon 1 of the FMR1 gene. The co-occurrence of FXS with other genetic disorders has only been occasionally reported. Here, we describe three independent cases of FXS co-segregation with three different genetic conditions, consisting of Duchenne muscular dystrophy (DMD), PPP2R5D–related neurodevelopmental disorder, and 2p25.3 deletion. The co-occurrence of DMD and FXS has been reported only once in a young boy, while in an independent family two affected boys were described, the elder diagnosed with FXS and the younger with DMD. This represents the second case in which both conditions coexist in a 5-year-old boy, inherited from his heterozygous mother. The next double diagnosis had never been reported before: through exome sequencing, a girl with FXS who was of 7 years of age with macrocephaly and severe psychomotor delay was found to carry a de novo variant in the PPP2R5D gene. Finally, a maternally inherited 2p25.3 deletion associated with a decreased level of the MYT1L transcript, only in the patient, was observed in a 33-year-old FXS male with severe seizures compared to his mother and two sex-and age-matched controls. All of these patients represent very rare instances of genetic conditions with clinical features that can be modified by FXS and vice versa.
KW - 2p25.3 deletion
KW - Adult
KW - Child
KW - Child, Preschool
KW - Duchenne muscular dystrophy
KW - Female
KW - Fragile X Mental Retardation Protein
KW - Fragile X Syndrome
KW - Fragile X syndrome
KW - Humans
KW - Male
KW - Megalencephaly
KW - Muscular Dystrophy, Duchenne
KW - Mutation
KW - Nerve Tissue Proteins
KW - PPP2R5D gene
KW - Personalized medicine
KW - Protein Phosphatase 2
KW - Transcription Factors
KW - Whole Exome Sequencing
KW - 2p25.3 deletion
KW - Adult
KW - Child
KW - Child, Preschool
KW - Duchenne muscular dystrophy
KW - Female
KW - Fragile X Mental Retardation Protein
KW - Fragile X Syndrome
KW - Fragile X syndrome
KW - Humans
KW - Male
KW - Megalencephaly
KW - Muscular Dystrophy, Duchenne
KW - Mutation
KW - Nerve Tissue Proteins
KW - PPP2R5D gene
KW - Personalized medicine
KW - Protein Phosphatase 2
KW - Transcription Factors
KW - Whole Exome Sequencing
UR - http://hdl.handle.net/10807/206468
U2 - 10.3390/genes12121909
DO - 10.3390/genes12121909
M3 - Article
SN - 2073-4425
VL - 12
SP - 1909-N/A
JO - Genes
JF - Genes
ER -